Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Coronavirus Breakthrough: New Study Highlights Senhwa Biosciences Silmitasertib as Potential Treatment for COVID-19 2020-07-01 21:00
Senhwa Biosciences Silmitasertib Named as Potential COVID-19 Therapy 2020-03-31 19:00
Senhwa Biosciences Reports Positive Phase 1 Data of CX-5461 in Patients With Advanced Solid Tumors at 2019 SABCS 2019-12-13 04:00
Senhwa Biosciences Silmitasertib / Basal Cell Carcinoma Trial Completed 1st Patient Enrollment 2019-04-17 19:00
1 2